ARCHIVES

“Treatment INDs” Seen As Major Threat To Clinical Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 34 | August 21, 1987

Download PDF Visit The Full Archive

Related Articles

Book By Clinical Researcher Makes Case For Nationwide Reforms

July 30, 1993

NEJM Sanctioned For Giving CME Credit For Controversial Lung Screening Paper; ACCME Demanded Corrective Action

January 9, 2009

CCRAC Approves New Grant Program For Studies Of Cancer Patient Compliance RFA to Be Issued

May 16, 1980

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

February 25, 2011

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

July 11, 2014

Requiring Survival Data Was Logical In 1950s, Not Today, Broder Says

January 13, 1989